Idexx Laboratories | IDXX - Operating Profit

Stock Price
545.09
Daily Change
16.30 3.08%
Monthly
-6.51%
Yearly
4.49%
Q2 Forecast
518.16

Idexx Laboratories reported $362.59M in Operating Profit for its fiscal quarter ending in March of 2026.





Operating Profit Change Date
Abbott USD 1.85B 399M Mar/2026
Accuray USD 4.71M 6.86M Dec/2024
Align Technology USD 178.05M 46.66M Mar/2026
AngioDynamics USD -2.51M 5.41M Sep/2025
Dentsply International USD 32M 506M Mar/2026
Dexcom USD 255.3M 67.7M Mar/2026
Edwards Lifesciences USD 514.7M 144.4M Mar/2026
Fujifilm JPY 101.76B 11.79B Mar/2026
Globus Medical USD 164M 17.31M Mar/2026
Henry Schein USD 182M 4M Mar/2026
Idexx Laboratories USD 362.59M 46.98M Mar/2026
Inogen USD -7.79M 728K Sep/2024
Insulet USD 122M 24.3M Mar/2026
Integra LifeSciences USD 11.47M 54.54M Mar/2026
Intuitive Surgical USD 859.7M 5.6M Mar/2026
Masimo USD 77.4M 6.5M Mar/2026
Neogen USD -3.3M 2.08M Dec/2025
Orthofix International USD 6.12M 1.91M Dec/2025
Phibro Animal Health USD 54.99M 2.36M Dec/2025
ResMed USD 505.67M 8.07M Mar/2026
Roche Holding CHF 9.56B 3.8B Dec/2025
Steris USD 318.7M 40.7M Mar/2026
Tandem Diabetes Care USD 8.29M 31.16M Dec/2025
Teleflex USD 37.03M 686K Mar/2026
Thermo Fisher Scientific USD 1.91B 389M Mar/2026
Zoetis USD 865M 30M Mar/2026